<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://sti.bmj.com">
<title>Sexually Transmitted Infections current issue</title>
<link>http://sti.bmj.com</link>
<description>Sexually Transmitted Infections RSS feed -- current issue</description>
<prism:coverDisplayDate>Jun  1 2012 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Sexually Transmitted Infections</prism:publicationName>
<prism:issn>1368-4973</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/235?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/236?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/238?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/239?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/240?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/249?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/250?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/252?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/258?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/264?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/266?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/271?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/272?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/278?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/283?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/284?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/288?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/294?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/300?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/301?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/304?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/307?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/312?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/88/4/313?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://sti.bmj.com/site/homepage/STI_95x60.gif" />
</channel>
<image rdf:about="http://sti.bmj.com/site/homepage/STI_95x60.gif">
<title>Sexually Transmitted Infections</title>
<url>http://sti.bmj.com/site/homepage/STI_95x60.gif</url>
<link>http://sti.bmj.com</link>
</image>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/235?rss=1">
<title><![CDATA[Highlights from this issue]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/235?rss=1</link>
<description><![CDATA[ <p>By the time you read this, Olympic fever will be upon those of us in the UK&mdash;leave is cancelled in the public health agencies, road closure imminent, and a frenzy of emergency planning and resilience exercises is reaching its final stages. Where does sexual health fit in to Olympic preparation? Traditionally, large construction projects and major public events have been seen a magnet for sex work, bringing together large communities of men living apart from partners and families. A before and after analysis exploring Canada's 2010 Winter Olympics suggests that an influx of sex workers is no longer to be expected in a developed setting, but displacement and perceived police harassment need to be addressed.<cross-ref type="bib" refid="b1">1</cross-ref> Significantly, the researchers noted no increase in new reports of youth or trafficked sex workers. Some of our editors are involved in work to assess impact in the UK&mdash;watch this space!</p> <p>In...]]></description>
<dc:creator><![CDATA[Cassell, J. A.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050621</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050621</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, Reproductive medicine, Adolescent health, Child health, Condoms, HIV / AIDS, Gonorrhoea, HIV infections, Sex workers, Urethritis, Vulvovaginal disorders, Confidentiality]]></dc:subject>
<dc:title><![CDATA[Highlights from this issue]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Whistlestop tour</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>235</prism:startingPage>
<prism:endingPage>235</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/236?rss=1">
<title><![CDATA[Health inequalities among sexual minority youth: a need for sexual orientation and gender expression sensitive school environment]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/236?rss=1</link>
<description><![CDATA[ <p>Sexual minority youth bear a disproportionate burden of HIV, other sexually transmitted infections, depression, suicide, homelessness and substance abuse compared with heterosexual youth.<cross-ref type="bib" refid="b1">1&ndash;5</cross-ref><cross-ref type="bib" refid="b2"></cross-ref><cross-ref type="bib" refid="b3"></cross-ref><cross-ref type="bib" refid="b4"></cross-ref><cross-ref type="bib" refid="b5"></cross-ref> The term, &lsquo;sexual minority youth&rsquo;, has been used in the literature to refer to bisexual, gay, lesbian, transgender, queer and questioning youth. Without dissolving the distinction and diversity among and within the various groups that make up sexual minority youth, it is also important to acknowledge some similarities that may promote the health inequalities. Discrimination, stigma, rejection and violence characterise the lives of sexual minority youth. This editorial will summarise the current state of interventions for sexual minority youth with a particular focus on school-based programmes. The discussion will also highlight the importance of political support in establishing sexual orientation and gender sensitive school environments and outline lessons learnt from existing programmes.</p> <p>Adolescence is a challenging...]]></description>
<dc:creator><![CDATA[Gebrekristos, H. T.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050522</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050522</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Health inequalities among sexual minority youth: a need for sexual orientation and gender expression sensitive school environment]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Editorial</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>236</prism:startingPage>
<prism:endingPage>237</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/238?rss=1">
<title><![CDATA[Genital malodour in women: an unmet therapeutic challenge]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/238?rss=1</link>
<description><![CDATA[ <sec><st>Introduction</st> <p>Unpleasant odour originating in or localised to the genital area is a not an uncommon symptom that brings a woman to her practitioner's office. In reality, women are frequently too embarrassed to discuss this symptom and only a fraction with this distressing complaint seek treatment. Not all malodour is persistent and when seeking medical help, frequently, the complaint of malodour only emerges well into a discussion of her other complaints of discharge, irritation, etc. Women reporting long-standing genital malodour are usually mortified, especially if another individual(s) has mentioned the odour to the patient. This may be a sexual partner, family member or most horrifically an associate or co-worker. When the complaint eventually emerges, the clinician faces anything but an easy task in tracking down causation. The practitioner cannot expect much assistance from medical textbooks or other gynaecological literature. Traditionally, textbooks use an approach based upon specific diagnostic entities...]]></description>
<dc:creator><![CDATA[Sobel, J. D.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050440</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050440</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Genital malodour in women: an unmet therapeutic challenge]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Editorial</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>238</prism:startingPage>
<prism:endingPage>238</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/239?rss=1">
<title><![CDATA[Why we like clinical guidelines]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/239?rss=1</link>
<description><![CDATA[ <p>"What are the best things about BASHH (British Association for Sexual Health and HIV)?" was a question posed in the strategy consultation held in August 2011. Patient care and clinical governance was seen as an &lsquo;extremely high&rsquo; priority for BASHH by almost everyone responding, and the &lsquo;best thing&rsquo; chosen by 96% of the 258 members participating were the clinical guidelines (J Wilson, personal communication). These were given as the main reasons for using the BASHH website by 98% of those responding, and were said to be &lsquo;completely&rsquo; or &lsquo;mostly&rsquo; relevant to their clinical practice. The usage figures for the website substantiate this, with the guidelines receiving nearly 100 000 hits each year,<cross-ref type="bib" refid="b1">1</cross-ref> a dramatic growth since the first national guideline (gonorrhoea) was published in 1996.</p> <p>At that time, the Clinical Effectiveness Unit of the Royal College of Physicians, was beginning to apply structured methods of guideline evaluation, notably...]]></description>
<dc:creator><![CDATA[FitzGerald, M., Kingston, M. A., BASHH Clinical Effectiveness Group]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050533</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050533</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Patients, Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, Chlamydia, Gonorrhoea, HIV infections, Urethritis, Vulvovaginal disorders, Guidelines]]></dc:subject>
<dc:title><![CDATA[Why we like clinical guidelines]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>BASHH column</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>239</prism:startingPage>
<prism:endingPage>239</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/240?rss=1">
<title><![CDATA[Knowing your HIV/AIDS epidemic and tailoring an effective response: how did India do it?]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/240?rss=1</link>
<description><![CDATA[
<p>Tremendous global efforts have been made to collect data on the HIV/AIDS epidemic. Yet, significant challenges remain for generating and analysing evidence to allocate resources efficiently and implement an effective AIDS response. India offers important lessons and a model for intelligent and integrated use of data on HIV/AIDS for an evidence-based response. Over the past 15&nbsp;years, the number of data sources has expanded and the geographical unit of data generation, analysis and use for planning has shifted from the national to the state, district and now subdistrict level. The authors describe and critically analyse the evolution of data sets in India and how they have been utilised to better understand the epidemic, advance policy, and plan and implement an increasingly effective, well-targeted and decentralised national response to HIV and AIDS. The authors argue that India is an example of how &lsquo;know your epidemic, know your response&rsquo; message can effectively be implemented at scale and presents important lessons to help other countries design their evidence generation systems.</p>
]]></description>
<dc:creator><![CDATA[Sgaier, S. K., Claeson, M., Gilks, C., Ramesh, B. M., Ghys, P. D., Wadhwani, A., Ramakrishnan, A., Tangri, A., K, C.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050382</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050382</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Unlocked, Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, HIV infections]]></dc:subject>
<dc:title><![CDATA[Knowing your HIV/AIDS epidemic and tailoring an effective response: how did India do it?]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Programme science</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>240</prism:startingPage>
<prism:endingPage>249</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/249?rss=1">
<title><![CDATA[Methods of assessing tubal patency]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/249?rss=1</link>
<description><![CDATA[ <p>Bender and colleagues found that relationships between levels of chlamydia infection and complication rates of pelvic inflammatory disease and ectopic pregnancy between and within countries over time were not straightforward.<cross-ref type="bib" refid="b1">1</cross-ref> Many women diagnosed with a chlamydial infection are anxious about future fertility. Fertiloscopy is a novel procedure to assess fallopian tube function and may be a suitable alternative to the gold standard diagnostic of laparoscopy.<cross-ref type="bib" refid="b2">2</cross-ref> It is done under local anaesthesia and may involve transvaginal hydrolaparoscopy, methylene blue dye test, salpingoscopy, microsalpingoscopy and hysteroscopy. The main feature of fertiloscopy is that it allows an optical device to be introduced into the tubal ostium to bilaterally explore the tubal mucosa. Optical magnification allows the assessment of the functional capability of the fallopian tubes. This may guide decisions about referral for other treatments such as in vitro fertilisation.<cross-ref type="bib" refid="b2">2</cross-ref> Little is known about women's attitudes towards...]]></description>
<dc:creator><![CDATA[Jagadambe, A., Oakeshott, P., Ojha, K., Hay, P. E.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050559</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050559</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Methods of assessing tubal patency]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Miscellaneous</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>249</prism:startingPage>
<prism:endingPage>249</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/250?rss=1">
<title><![CDATA[Inguinal syndrome secondary to Prevotella bivia after accidental bite in orogenital sex]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/250?rss=1</link>
<description><![CDATA[
<p>The authors report a case of an inguinal bubo in a young man caused by an anaerobe, <I>Prevotella bivia</I>, which was acquired during oral sexual intercourse. As far as the authors know, this is the first reported case of a sexually transmitted infection by <I>Prevotella</I>. <I>Prevotella</I> spp. inhabit the oral cavity and are highly prevalent in bacterial vaginosis, a polymicrobial syndrome resulting from replacement of the normal vaginal Lactobacillus spp. flora by high concentrations of anaerobic microorganisms such as <I>Prevotella</I> spp., <I>Mobiluncus</I> spp., <I>Gardnerella vaginalis</I> and other uncultivated anaerobes.</p>
]]></description>
<dc:creator><![CDATA[Sagrista, M., Martin-Ezquerra, G., Gallardo, F., Membrilla, E., Salazar, A. J., Salvado, M., Gomez, J., Pujol, R. M.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050348</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050348</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, Vulvovaginal disorders, Health education]]></dc:subject>
<dc:title><![CDATA[Inguinal syndrome secondary to Prevotella bivia after accidental bite in orogenital sex]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Clinical</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>250</prism:startingPage>
<prism:endingPage>251</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/252?rss=1">
<title><![CDATA[Age at first anal sex and HIV/STI vulnerability among gay men in Australia]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/252?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To determine whether there is a link between age at first anal intercourse (AFAI) and gay men's HIV/sexually transmissible infection (STI) vulnerability, including tendencies to engage in higher risk sexual behaviour.</p>
</sec>
<sec><st>Methods</st>
<p>A nationwide cross-sectional survey was conducted online involving 845 Australian gay men born between 1944 and 1993.</p>
</sec>
<sec><st>Results</st>
<p>Median AFAI fell from 35&nbsp;years for men born between 1944 and 1953 to 18&nbsp;years for men born between 1984 and 1993. Of those who reported having had anal intercourse (N=822), HIV-positive men were found to be significantly younger on average when they first had anal intercourse compared with HIV-negative men (18.5 vs 21.3&nbsp;years, p&lt;0.001). Men with a history of other STIs were also significantly younger. Engaging in higher risk sexual behaviour is a likely factor, with AFAI generally younger among men who reported &gt;10 sexual partners in the past year (p&lt;0.001) and who engaged in group sex (p&lt;0.001), receptive anal intercourse (p=0.008) or were drug or alcohol affected (p=0.06) during their most recent sexual encounter.</p>
</sec>
<sec><st>Conclusions</st>
<p>There appears to be a strong link between AFAI and infection with HIV/STIs, as well as tendencies to engage in higher risk sexual behaviour. While further research is needed to understand this link, these findings highlight a need for sexuality education aimed at gay-identified youth to ensure their sexual debut does not lead to poorer sexual health outcomes.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Lyons, A., Pitts, M., Grierson, J., Smith, A., McNally, S., Couch, M.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050253</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050253</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Editor's choice, Drugs: infectious diseases, HIV/AIDS, Adolescent health, Child health, HIV / AIDS, HIV infections, Health education]]></dc:subject>
<dc:title><![CDATA[Age at first anal sex and HIV/STI vulnerability among gay men in Australia]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Behaviour</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>252</prism:startingPage>
<prism:endingPage>257</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/258?rss=1">
<title><![CDATA[Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/258?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To investigate willingness to use HIV pre-exposure prophylaxis (PrEP) and the likelihood of decreased condom use among Australian gay and bisexual men.</p>
</sec>
<sec><st>Methods</st>
<p>A national, online cross-sectional survey was conducted in April to May 2011. Bivariate relationships were assessed with <sup>2</sup> or Fisher's exact test. Multivariate logistic regression analysis was performed to assess independent relationships with primary outcome variables.</p>
</sec>
<sec><st>Results</st>
<p>Responses from 1161 HIV-negative and untested men were analysed. Prior use of antiretroviral drugs as PrEP was rare (n=6). Just over a quarter of the sample (n=327; 28.2%) was classified as willing to use PrEP. Willingness to use PrEP was independently associated with younger age, having anal intercourse with casual partners (protected or unprotected), having fewer concerns about PrEP and perceiving oneself to be at risk of HIV. Among men who were willing to use PrEP (n=327), only 26 men (8.0%) indicated that they would be less likely to use condoms if using PrEP. The likelihood of decreased condom use was independently associated with older age, unprotected anal intercourse with casual partners (UAIC) and perceiving oneself to be at increased risk of HIV.</p>
</sec>
<sec><st>Conclusions</st>
<p>The Australian gay and bisexual men the authors surveyed were cautiously optimistic about PrEP. The minority of men who expressed willingness to use PrEP appear to be appropriate candidates, given that they are likely to report UAIC and to perceive themselves to be at risk of HIV.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Holt, M., Murphy, D. A., Callander, D., Ellard, J., Rosengarten, M., Kippax, S. C., de Wit, J. B. F.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050312</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050312</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, Reproductive medicine, Condoms, HIV / AIDS, HIV infections]]></dc:subject>
<dc:title><![CDATA[Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Behaviour</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>258</prism:startingPage>
<prism:endingPage>263</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/264?rss=1">
<title><![CDATA[Advertisements promoting human papillomavirus vaccine for adolescent boys: does source matter?]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/264?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Many parents recall hearing of human papillomavirus (HPV) vaccine through drug company advertisements. This study sought to examine whether parents accurately recall the source (ie, sponsor) of advertisements promoting HPV vaccine and the impact of drug company advertisements.</p>
</sec>
<sec><st>Methods</st>
<p>A US national sample of 544 parents of adolescent boys aged 11&ndash;17 participated in an online between-subjects experiment. Parents viewed an advertisement encouraging HPV vaccination for boys with a logo from a randomly assigned source. Parents rated trust, likability and motivation for vaccination while viewing the advertisement and later indicated who they believed sponsored it.</p>
</sec>
<sec><st>Results</st>
<p>Nearly half (43%) of parents who viewed a hypothetical advertisement containing a logo incorrectly identified the advertisement source. More parents correctly identified the source of drug company advertisements than advertisement from other sources (62% vs 25%, OR 4.93, 95% CI 3.26 to 7.46). The majority of parents who saw a logo-free advertisement believed a drug company created it (60%). Among parents who correctly identified the advertisement source, drug company advertisements decreased motivation to vaccinate their sons, an association mediated by reduced liking of and trust in the advertisements.</p>
</sec>
<sec><st>Conclusions</st>
<p>Parents were more accurate in identifying drug company advertisements, primarily because they tended to assume any advertisement was from a drug company. Public health organisations may need to take special measures to ensure their messages are not perceived as sponsored by drug companies.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Pepper, J. K., Reiter, P. L., McRee, A.-L., Brewer, N. T.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050197</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050197</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, Vaccination / immunisation]]></dc:subject>
<dc:title><![CDATA[Advertisements promoting human papillomavirus vaccine for adolescent boys: does source matter?]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Behaviour</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>264</prism:startingPage>
<prism:endingPage>265</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/266?rss=1">
<title><![CDATA[Gonorrhoea or chlamydia in a US military HIV-positive cohort]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/266?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To investigate the epidemiology and risk factors of gonorrhoea (GC) or chlamydia (CT) coinfection in an HIV-positive US military cohort, focusing on the time after participants' knowledge of HIV diagnosis.</p>
</sec>
<sec><st>Methods</st>
<p>The authors analysed data from 4461 participants enrolled in the US Military Natural History Study cohort for GC or CT infection &ge;6&nbsp;months after their HIV-positive test.</p>
</sec>
<sec><st>Results</st>
<p>During a mean follow-up of 7.08&nbsp;years, 482 (11%) participants acquired a GC or CT infection. Of these, 283 (6%) acquired a GC infection, 278 (6%) acquired a CT infection and 123 (3%) had multiple GC or CT infections during follow-up. Risk of GC or CT infection was significantly greater in those younger, male, African&ndash;American and with a history of GC or CT infection.</p>
</sec>
<sec><st>Conclusions</st>
<p>Frequent GC and CT diagnoses observed among members of this HIV-positive cohort indicate substantial ongoing risk behaviours that raise concerns for HIV transmission and underscore the need for continued screening to help identify and treat these sexually transmitted infections in this population.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Spaulding, A. B., Lifson, A. R., Iverson, E. R., Ganesan, A., Landrum, M. L., Weintrob, A. C., Agan, B. K., Bavaro, M. F., O'Connell, R. J., Macalino, G. E., the Infectious Disease Clinical Research Program HIV Working Group]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050173</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050173</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, Gonorrhoea, HIV infections, Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Gonorrhoea or chlamydia in a US military HIV-positive cohort]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>266</prism:startingPage>
<prism:endingPage>271</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/271?rss=1">
<title><![CDATA[The Origins of AIDS]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/271?rss=1</link>
<description><![CDATA[ <p>It would be difficult to imagine anyone better qualified than Jacques Pepin to write about the origins of AIDS. An infectious diseases specialist who worked for 4&nbsp;years in a bush hospital in Zaire (now the Democratic Republic of Congo), he trained in epidemiology at the London School of Hygiene &amp; Tropical Medicine, has an encyclopaedic knowledge of French and Belgian colonial history, and has himself conducted groundbreaking research on the epidemiology of HIV-2 in West Africa.</p> <p>This book reads like a detective story, and I found it hard to put down. Starting with the virological evidence that simian immunodeficiency virus in chimpanzees (SIV<SUB>cpz</SUB>) was first transmitted to a human around 1920, Pepin takes us through the evidence underlying the &lsquo;cut hunter&rsquo; hypothesis as to how his might have happened, the social life and geographical distribution of various subspecies of chimpanzee and the retroviruses that they harbour, and the heroic...]]></description>
<dc:creator><![CDATA[Mabey, D.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050411</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050411</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[The Origins of AIDS]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Miscellaneous</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>271</prism:startingPage>
<prism:endingPage>271</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/272?rss=1">
<title><![CDATA[Molecular epidemiology of genital Chlamydia trachomatis infection in Shenzhen, China]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/272?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To investigate molecular epidemiology of <I>Chlamydia trachomatis</I> infection among patients recruited from different clinic settings in Shenzhen, China.</p>
</sec>
<sec><st>Methods</st>
<p>A total of 2534 patients from the sexually transmitted disease (STD) clinics, obstetrics and gynaecology (OBGYN) clinics and genitourinary medicine (GUM) clinics in 34 hospitals participated in the study. The <I>C trachomatis</I> infection was determined using COBAS Amplicor system. DNA extracted in <I>C trachomatis</I>-positive samples was amplified using a nested PCR based on <I>omp</I>A gene and then genotyped using a microsphere suspension array.</p>
</sec>
<sec><st>Results</st>
<p>The overall prevalence of genital <I>C trachomatis</I> infection was 17.7%. The prevalence in patients at STD or GUM clinics was significantly higher than that in patients at OBGYN clinics. Being male (adjusted OR (AOR) 2.5, 95% CI 1.8 to 3.4), having no consistent use of a condom with casual partners in the past 3&nbsp;months (AOR 1.7, 95% CI 1.1 to 2.8) and having any STD symptoms (AOR 3.3, 95% CI 2.0 to 5.4) were independently associated with <I>C trachomatis</I> infection. Eight genotypes were identified. The most prevalent genotypes were F (22.3%), E (22.0%) and D/Da (12.7%). Other genotypes were G/Ga (8.0%), J (7.3%), K (2.7%), H (2.7%) and I/Ia (0.4%). Eighty-two samples (18.3%) were infected with multiple genotypes. Genotype D/Da among patients from GUM clinics was more common than those from STD or OBGYN clinics. Infections with genotypes G and F were statistically associated with abnormal vaginal discharge (p=0.001) and being married (p=0.014), respectively. Infection with multiple genotypes was more common among patients with a higher income (p=0.011).</p>
</sec>
<sec><st>Conclusion</st>
<p>A substantial prevalence of genital <I>C trachomatis</I> infection in Shenzhen suggests the importance of detection and treatment of the infection in high-risk groups.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Zhang, J.-J., Zhao, G.-L., Wang, F., Hong, F.-C., Luo, Z.-Z., Lan, L.-N., Zhang, C.-L., Peng, Y., Liu, X.-L., Feng, T.-J., Chen, X.-S.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050163</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050163</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, Reproductive medicine, Ophthalmology, Condoms, Chlamydia]]></dc:subject>
<dc:title><![CDATA[Molecular epidemiology of genital Chlamydia trachomatis infection in Shenzhen, China]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>272</prism:startingPage>
<prism:endingPage>277</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/278?rss=1">
<title><![CDATA[Injection drug use, sexual risk, violence and STI/HIV among Moscow female sex workers]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/278?rss=1</link>
<description><![CDATA[
<sec><st>Background/objectives</st>
<p>The HIV prevalence in Eastern Europe and Central Asia continues to increase. While injection drug use (IDU) is leading factor, heterosexual transmission is on the rise. Little is known about female sex workers (FSWs) in the region despite the central role of commercial sex in heterosexual sexually transmitted infection (STI)/HIV transmission globally. The authors evaluated the prevalence of STI/HIV among Moscow-based FSWs and potential risk factors including IDU, sexual risks and violence victimisation.</p>
</sec>
<sec><st>Methods</st>
<p>Moscow-based FSWs (n=147) completed a clinic-based survey and STI/HIV testing over an 8-month period in 2005.</p>
</sec>
<sec><st>Results</st>
<p>HIV prevalence was 4.8%, and 31.3% were infected with at least one STI including HIV. Sexual behaviours significantly associated with STI/HIV included anal sex (adjusted odds ratio (AOR) 3.48), high client volume (three or more clients daily, AOR 2.71), recent <I>subbotnik</I> (sex demanded by police; AOR 2.50) and regularly being presented with more clients than initially agreed to (AOR 2.45). Past year experiences of physical violence from clients and threats of violence from pimps were associated with STI/HIV (AOR 3.14 and AOR 3.65, respectively). IDU was not significantly associated with STI/HIV. Anal sex and high client volume partially mediated the associations of abuse with STI/HIV.</p>
</sec>
<sec><st>Conclusions</st>
<p>Findings illustrate substantial potential for heterosexual STI/HIV transmission in a setting better known for IDU-related risk. Many of the STI/HIV risks observed are not modifiable by FSWs alone. STI/HIV prevention efforts for this vulnerable population will benefit from reducing coercion and abuse perpetrated by pimps and clients.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Decker, M. R., Wirtz, A. L., Baral, S. D., Peryshkina, A., Mogilnyi, V., Weber, R. A., Stachowiak, J., Go, V., Beyrer, C.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050171</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050171</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, HIV infections, Sex workers]]></dc:subject>
<dc:title><![CDATA[Injection drug use, sexual risk, violence and STI/HIV among Moscow female sex workers]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>278</prism:startingPage>
<prism:endingPage>283</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/283?rss=1">
<title><![CDATA[Medical care for sexual assault victims]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/283?rss=1</link>
<description><![CDATA[ <p>The recently published article by Chacko L <I>et al</I><cross-ref type="bib" refid="b1">1</cross-ref> contributes greatly to our understanding of the extent of poor adherence to post-exposure prophylaxis in victims of sexual assault. It also clarifies the percentage of such patients defaulting from care. The article illustrates how victims of sexual assault fail to adhere to guidelines for prevention of HIV infection.<cross-ref type="bib" refid="b1">1</cross-ref></p> <p>Sadler AG <I>et al</I><cross-ref type="bib" refid="b2">2</cross-ref> reveal that female victims of military sexual trauma have an increased risk of cervical cytological abnormalities. This increased gynaecological health risk factor requires vigilance in long-term screening to prevent poor future outcomes. The adherence of women veterans to cervical cancer screening is imperative for their future welfare.<cross-ref type="bib" refid="b2">2</cross-ref> <cross-ref type="bib" refid="b3">3</cross-ref></p> <p>This recent publication of Chacko L <I>et al</I> thus reflects the poor adherence of victims of sexual assault in the prevention of HIV infection.<cross-ref type="bib" refid="b1">1</cross-ref></p> <p>Up to 40% of...]]></description>
<dc:creator><![CDATA[Lutwak, N.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050586</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050586</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Medical care for sexual assault victims]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Miscellaneous</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>283</prism:startingPage>
<prism:endingPage>283</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/284?rss=1">
<title><![CDATA[Sensitivity of Gram stain in the diagnosis of urethritis in men]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/284?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Acute urethritis is among the most common types of sexually transmitted diseases in men. The diagnosis usually requires microscopic evidence of urethritis, but sometimes urethral pathogens are detected in asymptomatic men without such evidence. The aims of this study were to assess the sensitivity of Gram stain in men with urethral symptoms and to relate it to the microorganisms isolated.</p>
</sec>
<sec><st>Methods</st>
<p>Between January 2006 and December 2007, 491 urethral samples were analysed. The authors assessed the presence of leukocytes by Gram stain and tested specifically for <I>Chlamydia</I> <I>trachomatis</I>, <I>Ureaplasma urealyticum</I>, <I>Mycoplasma hominis</I> and <I>Trichomonas vaginalis</I>, as well as analysing the results of conventional culture.</p>
</sec>
<sec><st>Results</st>
<p>The percentages of positive samples as a function of Gram category were two or less polymorphonuclear leukocytes (PMNLs)/high-power field (HPF) 25% (92/364), three to four PMNLs/HPF 32% (18/57) and five or more PMNLs/HPF 54% (38/70). Classing samples with more than two PMNLs/HPF as positive, the sensitivity, specificity and positive likelihood ratio for Gram stain were 38% (95% CI 30 to 46), 79% (95% CI 75 to 84) and 1.8 (95% CI 1.4 to 2.4), respectively. On the other hand, taking as positive five or more PMNLs/HPF, the sensitivity, specificity and positive likelihood ratio for Gram stain were 26% (95% CI 18 to 33), 91% (95% CI 87 to 94) and 2.7 (95% CI 1.8 to 4.2), respectively. The sensitivity of Gram stain to <I>Neisseria gonorrhoeae</I>, <I>Chlamydia trachomatis</I> and <I>Ureaplasma urealyticum</I> were 80% (95% CI 64 to 96), 23% (95% CI 8 to 39) and 11% (95% CI 2 to 20), respectively.</p>
</sec>
<sec><st>Conclusion</st>
<p>The low sensitivity of Gram stain means that negative results do not exclude the presence of urethritis in symptomatic patients.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Orellana, M. A., Gomez-Lus, M. L., Lora, D.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050150</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050150</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, Ophthalmology, Chlamydia, Urethritis, Vulvovaginal disorders]]></dc:subject>
<dc:title><![CDATA[Sensitivity of Gram stain in the diagnosis of urethritis in men]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>284</prism:startingPage>
<prism:endingPage>287</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/288?rss=1">
<title><![CDATA[High prevalence of HIV and sexually transmitted infections among male sex workers in Abidjan, Cote d'Ivoire: need for services tailored to their needs]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/288?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To assess condom use and prevalence of sexually transmitted infections (STI) and HIV among male sex workers (MSW) in Abidjan, C&ocirc;te d'Ivoire.</p>
</sec>
<sec><st>Methods</st>
<p>A cross-sectional survey was conducted between October 2007 and January 2008 among MSW attending a sex worker clinic in Abidjan. A short questionnaire was administered in a face-to-face interview, and the participants were asked to provide a urine sample for STI testing and to self-collect transudate of the gingival mucosa for anonymous HIV testing, using a rapid test. A rectal swab for STI testing was taken by a physician. Molecular amplification assays were performed for the detection of <I>Chlamydia trachomatis</I>, <I>Neisseria gonorrhoeae</I> and <I>Trichomonas vaginalis</I>.</p>
</sec>
<sec><st>Results</st>
<p>96 MSW participated in the survey, their median age was 27&nbsp;years and the median duration of sex work was 5&nbsp;years. Consistent condom use with clients during the last working day was 86.0%, and consistent condom use with the regular partner during the last week was 81.6%. HIV infection was detected in 50.0% of the participants. The prevalence of <I>N gonorrhoeae</I> was 12.8%, chlamydia infection was present in 3.2% and <I>T</I> <I>vaginalis</I> in 2.1% of the study participants.</p>
</sec>
<sec><st>Conclusions</st>
<p>HIV and STI rates found in this study confirm the high risk and vulnerability status of MSW in C&ocirc;te d'Ivoire. There is a definite need for studies exploring risk and risk perceptions among MSW in more depth and for services tailored to their needs, including developing and validating simple algorithms for the diagnosis of STI in MSW and men who have sex with men.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Vuylsteke, B., Semde, G., Sika, L., Crucitti, T., Ettiegne Traore, V., Buve, A., Laga, M.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050276</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050276</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Unlocked, Drugs: infectious diseases, HIV/AIDS, Reproductive medicine, Ophthalmology, Condoms, HIV / AIDS, Chlamydia, HIV infections, Sex workers]]></dc:subject>
<dc:title><![CDATA[High prevalence of HIV and sexually transmitted infections among male sex workers in Abidjan, Cote d'Ivoire: need for services tailored to their needs]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>288</prism:startingPage>
<prism:endingPage>293</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/294?rss=1">
<title><![CDATA[HIV and sexually transmitted infections at the borderlands: situational analysis of sexual health in the Brazilian Amazon]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/294?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The borderlands are considered areas of increased vulnerability to HIV and sexually transmitted infections (STI). The study aimed to determine the STI/HIV prevalence and risk factors in the triple-border area of the Brazilian Amazon.</p>
</sec>
<sec><st>Methods</st>
<p>A situational analysis of sexual health was conducted in three cities of the Alto Solim&otilde;es region. This multicomponent research approach included key informant interviews, participant observations and mapping of places where people meet sexual partners. Volunteers recruited from the &lsquo;hot spots&rsquo; in each city were invited for interview and STI/HIV testing.</p>
</sec>
<sec><st>Results</st>
<p>Over 6&nbsp;months, 598 participants were recruited, 285 men of median age 28&nbsp;years (IQR, 23&ndash;37) and 313 women of median age 29&nbsp;years (IQR, 24&ndash;37). Overall, 49.3% reported a casual partner during the past 3&nbsp;months, but only 38.5% reported consistent condom use. The respective prevalences in men and women were <I>Neisseria gonorrhoeae</I> (1.1% and 0.3%), <I>Chlamydia trachomatis</I> (1.4% and 4.8%), high-risk human papillomavirus (14.4% and 24.0%), active syphilis (3.2% and 2.6%), herpes simplex virus type-2 (51.1% and 72.1%), hepatitis B virus (by hepatitis B virus surface antigen) (7.5% and 4.6%), hepatitis C virus (0.7% and 0.7%) and HIV (1.4% and 0.0%). Risk factors for viral STIs included female sex and age.</p>
</sec>
<sec><st>Conclusions</st>
<p>While the main conditions that contribute to the spread of HIV are in place in the triple-border area, the prevalence of bacterial STIs and HIV are still relatively low, providing a window of opportunity for interventions.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Benzaken, A., Sabido, M., Galban, E., Rodrigues Dutra, D. L., Leturiondo, A. L., Mayaud, P.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050309</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050309</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Liver disease, Drugs: infectious diseases, Hepatitis and other GI infections, HIV/AIDS, Reproductive medicine, Ophthalmology, Condoms, Hepatitis (sexual health), HIV / AIDS, Chlamydia, Syphilis, HIV infections]]></dc:subject>
<dc:title><![CDATA[HIV and sexually transmitted infections at the borderlands: situational analysis of sexual health in the Brazilian Amazon]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>294</prism:startingPage>
<prism:endingPage>300</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/300?rss=1">
<title><![CDATA[Acceptability of providing self-taken vaginal samples and allowing access to NHS numbers and medical records: feasibility study in young female genitourinary medicine clinic attenders]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/300?rss=1</link>
<description><![CDATA[ <p>Sinka and colleagues found that using self-taken vaginal swabs for human papillomavirus (HPV) testing was acceptable to young women who had defaulted from their initial HPV screening appointment at age 21.<cross-ref type="bib" refid="b1">1</cross-ref> However, the rate of return of postal samples was low (13%, 725/5500). In October 2011, we conducted a feasibility study to evaluate response rates of 16&ndash;24&nbsp;years old female genitourinary medicine clinic attenders to providing two self-taken vaginal swabs for <I>Chlamydia trachomatis</I> and <I>Mycoplasma genitalium</I> testing and allowing access to National Health Service numbers and medical records for follow-up. Women sitting in the female-only waiting area in the Courtyard Clinic at St George's Hospital were approached by female foundation year 2 research doctors or medical students and given a flier about the study. This explained that women aged under 25 were being asked to help in research by providing self-taken samples and completing a questionnaire and that...]]></description>
<dc:creator><![CDATA[Ellis, J., Green, R., Kerry, S. R., Jesuratnam, G., Rajamanoharan, A., Patel, R., Dominise, C., Dave, S., Stephenson, J. M., Oakeshott, P.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050567</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050567</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Acceptability of providing self-taken vaginal samples and allowing access to NHS numbers and medical records: feasibility study in young female genitourinary medicine clinic attenders]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Miscellaneous</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>300</prism:startingPage>
<prism:endingPage>300</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/301?rss=1">
<title><![CDATA[Sex work and the public health impacts of the 2010 Olympic Games]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/301?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The authors examined the impact of exposure to the 2010 Winter Olympics time period on outcomes measuring disruption of local sex work environments in Vancouver, Canada.</p>
</sec>
<sec><st>Methods</st>
<p>The authors conducted a before-and-after study, using multivariable logistic regression, to assess the relationship between exposure to the Olympics period (19 January&ndash;14 March 2010) versus the post-Olympics period (1 April&ndash;1 July 2010) and outcomes.</p>
</sec>
<sec><st>Results</st>
<p>This study included 207 youth (14+&nbsp;years) and adult sex workers (SWs) (Olympics: n=107; post-Olympics: n=100). SWs in the two periods were statistically similar, with an overall median age of 33&nbsp;years (IQR: 28&ndash;40), and 106 (51.2%) of indigenous ancestry or ethnic minority. In separate multivariable logistic regression models, the Olympics period remained statistically significantly associated with perceived heightened police harassment of SWs without arrest (adjusted ORs (AOR): 3.95, 95% CIs 1.92 to 8.14), decreased availability of clients (AOR: 1.97, 95% CIs 1.11 to 3.48) and increased difficulty meeting clients due to road closures/construction (AOR: 7.68, 95% CIs 2.46 to 23.98). There were no significantly increased odds in perceived reports of new (0.999), youth (0.536) or trafficked SWs (zero reports) in the Olympic period.</p>
</sec>
<sec><st>Conclusions</st>
<p>To reduce potential adverse public health impacts of enhanced police harassment and displacement of local sex work markets, results suggest that evidence-based public health strategies need to be adopted for host cities of future events (eg, the London 2012 Olympic Games), such as the removal of criminal sanctions targeting sex work and the piloting and rigorous evaluation of safer indoor work spaces.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Deering, K. N., Chettiar, J., Chan, K., Taylor, M., Montaner, J. S., Shannon, K.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050235</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050235</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Sex workers]]></dc:subject>
<dc:title><![CDATA[Sex work and the public health impacts of the 2010 Olympic Games]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>301</prism:startingPage>
<prism:endingPage>303</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/304?rss=1">
<title><![CDATA[Using recent infection testing algorithm tests in clinical practice]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/304?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Recent Infection Testing Algorithm (RITA) tests are used in public health surveillance to identify the incidence of recently acquired HIV infection. This can then be used to direct public health interventions and evaluate their effects. We aimed to outline how RITA tests may be used in clinical practice with individual patients, as well as highlighting the cautions needed.</p>
</sec>
<sec><st>Methods</st>
<p>The clinical and laboratory aspects of RITA tests have been reviewed in the paper together with their clinical applications.</p>
</sec>
<sec><st>Results</st>
<p>For individuals, RITA tests can help to confirm primary HIV infection and can be useful with elements of partner notification. However, careful evaluation of the result is required and it should be considered in conjunction with the clinical history and findings.</p>
</sec>
<sec><st>Conclusions</st>
<p>There are major epidemiological and public health advantages in using RITA testing but there are also advantages to using the RITA test on an individual basis, provided that it is used appropriately.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Carlin, E., Taha, Y.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050432</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050432</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, HIV infections, Confidentiality]]></dc:subject>
<dc:title><![CDATA[Using recent infection testing algorithm tests in clinical practice]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>How to do it</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>304</prism:startingPage>
<prism:endingPage>306</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/307?rss=1">
<title><![CDATA[The expansion of HIV-1 in colonial Leopoldville, 1950s: driven by STDs or STD control?]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/307?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To understand the factors that drove the exponential spread of HIV-1 in L&eacute;opoldville (Kinshasa) in the 1950s.</p>
</sec>
<sec><st>Methods</st>
<p>A review of colonial and post-colonial health service reports, medical publications, and demographic and social science research in L&eacute;opoldville.</p>
</sec>
<sec><st>Results</st>
<p>Sex work appeared early in the history of L&eacute;opoldville, driven by a strong gender imbalance. Throughout the colonial era, sex work was of a low-risk type, with &lsquo;free women&rsquo; having a few regular clients. This sufficed for the persistence of HIV-1, but probably not for the dramatic expansion that occurred in the 1950s. During that decade, genital ulcerative diseases were uncommon and their effect on HIV-1 transmission must have been modest. Circumstantial evidence indicates that this expansion may have been related to parenteral transmission of HIV-1 in the city's sexually transmitted disease clinic, where up to 500 injections were administered daily using syringes and needles that were merely rinsed between patients. Most intravenous injections were given to treat syphilis in patients who never had any clinical evidence of this disease but only had a positive non-treponemal serology, often because of prior yaws infection. An outbreak of &lsquo;inoculation hepatitis&rsquo; was reported among these patients in 1951&ndash;1952. It is only after the Congo's independence (1960) that, in a context of pauperisation, a pattern of sex work appeared in L&eacute;opoldville wherein women had sex with more than 1000 clients each year, allowing the sexual amplification of the virus.</p>
</sec>
<sec><st>Conclusions</st>
<p>It is plausible that the exponential amplification of HIV-1 in L&eacute;opoldville occurred mostly parenterally in the 1950s and sexually in the 1960s.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Pepin, J.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050277</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050277</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Liver disease, Drugs: infectious diseases, Hepatitis and other GI infections, HIV/AIDS, Hepatitis (sexual health), HIV / AIDS, Dermatology, Syphilis, HIV infections]]></dc:subject>
<dc:title><![CDATA[The expansion of HIV-1 in colonial Leopoldville, 1950s: driven by STDs or STD control?]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Review</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>307</prism:startingPage>
<prism:endingPage>312</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/312?rss=1">
<title><![CDATA[Utility of post-treatment follow-up visit at 3 months in patients treated for early syphilis]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/312?rss=1</link>
<description><![CDATA[ <p>The main aim of serological post-treatment follow-up in patients treated for early syphilis is to identify treatment failure or re-infection.<cross-ref type="bib" refid="b1">1</cross-ref> Most experts define treatment failure or re-infection as &lsquo;serological&rsquo; when the Venereal Disease Research Laboratory (VDRL) titre increases fourfold after treatment. In addition, poor serological response is represented as failure of the VDRL titre to decline fourfold within 6&nbsp;months after treatment.<cross-ref type="bib" refid="b2">2</cross-ref> <cross-ref type="bib" refid="b3">3</cross-ref> European guidelines recommend post-treatment clinical and serological follow-up at 1, 2, 3, 6 and 12&nbsp;months.<cross-ref type="bib" refid="b1">1</cross-ref> Guidelines of the Centers for Disease Control and Prevention stipulate that follow-up at 6 and 12&nbsp;months is sufficient.<cross-ref type="bib" refid="b2">2</cross-ref> Latest studies from the UK showed that the 1st and 2nd month follow-up visits can be safely omitted.<cross-ref type="bib" refid="b4">4</cross-ref></p> <p>Based on this, we conducted an observational study. Altogether, 71 patients with early syphilis who were treated in our department between May and November...]]></description>
<dc:creator><![CDATA[Pastuszczak, M., Jaworek, A. K., Jakiela, B., Wojas-Pelc, A.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050555</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050555</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Utility of post-treatment follow-up visit at 3 months in patients treated for early syphilis]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Miscellaneous</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>312</prism:startingPage>
<prism:endingPage>312</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/88/4/313?rss=1">
<title><![CDATA[Clinical round-up]]></title>
<link>http://sti.bmj.com/cgi/content/short/88/4/313?rss=1</link>
<description><![CDATA[ <sec><st>Injectable long-acting reversible contraceptive (iLARC) users at higher risk of HIV and <I>Chlamydia trachomatis</I> infections</st> <p>Intuitively, non-barrier forms of contraception increase the risk of sexually transmitted infections. Studies have attempted to quantify the extent of this risk but their results have not been entirely unidirectional. A group of researchers in Durban, South Africa aimed to prospectively analyse the effect of contraception and risk of HIV and Chlamydia in 2236 HIV-negative women<cross-ref type="bib" refid="b1">1</cross-ref> who were screened for a microbicidal vaginal gel versus placebo HIV prevention trial.<cross-ref type="bib" refid="b2">2</cross-ref></p> <p>All women received risk reduction counselling and access to free condoms. Demographic factors were collected at baseline. Self-reported sexual history and contraception use were collected and HIV testing performed at baseline and 3 monthly intervals. Chlamydia trachomatis nucleic acid amplification testing was performed at week 24 only. The primary outcome for the interventions trial was HIV seroconversion before 52&nbsp;weeks for which...]]></description>
<dc:creator><![CDATA[Desai, M.]]></dc:creator>
<dc:date>2012-05-12T04:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050548</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050548</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Clinical trials (epidemiology), Epidemiologic studies, Drugs: infectious diseases, HIV/AIDS, Contraception, Drugs: obstetrics and gynaecology, Pregnancy, Reproductive medicine, Ophthalmology, Condoms, HIV / AIDS, Chlamydia, HIV infections]]></dc:subject>
<dc:title><![CDATA[Clinical round-up]]></dc:title>
<prism:publicationDate>2012-06-01</prism:publicationDate>
<prism:section>Clinical round-up</prism:section>
<prism:volume>88</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>313</prism:startingPage>
<prism:endingPage>313</prism:endingPage>
</item>
</rdf:RDF>
